Thoracic
FDA: Class I recall of LivaNova’s LifeSPARC System
Editor's Note The Food and Drug Administration (FDA) on September 30 identified the recall by LivaNova (TandemLife) of its LifeSPARC System, Model LS-1000, as Class I, the most serious. The recall was initiated because of the risk of unintentional extended pump stop during Controller Critical Failure mode, caused by a…
Free Daily News
- Fall deaths among older adults have tripled, prescription drugs under scrutiny
- AI could shrink drug discovery from years to months, expert says
- AI vendors bet on guaranteed ROI as competition with Epic intensifies
- AMA 2026 CPT code set expands with AI, remote monitoring, leg revascularization updates
- PACU initiative cuts emergency response times from 9 to 2 minutes
- Survey: Depression, loneliness surge among young and low-income adults
- Kansas nurses warn licensing board’s rules leave them vulnerable to career-ending penalties
- CDC projects hospitalization burden for 2025–2026 respiratory season
- Hospital complaints surge as oversight gaps leave patients frustrated
- Ambulatory general surgery safe for older adults when patients are carefully selected
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement